Prevacid, Topamax Among Blockbusters Set To Lose Exclusivity In ’09
Executive Summary
At least four blockbuster drugs could face generic rivals in the U.S. for the first time in 2009
You may also be interested in...
Smaller DTC Budgets, But More Info-Packed Drug Ads Expected In 2009
Drug companies will continue to scale back funds for televised ads in 2009, largely in order to save money, but also because they are increasingly sensitive to public perception at a time when consumers are struggling financially
Smaller DTC Budgets, But More Info-Packed Drug Ads Expected In 2009
Drug companies will continue to scale back funds for televised ads in 2009, largely in order to save money, but also because they are increasingly sensitive to public perception at a time when consumers are struggling financially
FDA Puts Off Forest’s Fibromyalgia Drug Milnacipran
For unknown reasons, SSNRI spending weeks in regulatory limbo.